Billionaire Stanley Druckenmiller Just Bought Taiwan Semiconductor Stock. Is the Foundry Giant Still a Screaming Buy?

Duquesne Family Office increased its stake in Taiwan Semiconductor (TSM) by nearly 20% in Q2, making TSM its second-largest holding. The article argues the stock is backed by fundamentals despite being down >10% from its late-June high, with valuation described as below 20x next year’s expected earnings. It also highlights TSMC’s $200B+ Arizona manufacturing build and CEO expectations for elevated AI-chip demand through at least 2029–2030, framing this as a buy-and-hold opportunity tied to the AI arms race.

Analysis

TSM’s Arizona build-out is less about near-term earnings uplift than about lowering the market’s geopolitical discount rate. That matters because foundry multiples are partly a function of tail-risk perception; even a modest reduction in perceived supply interruption risk can support a higher forward multiple over 6-18 months. The flip side is that U.S. capacity is structurally more expensive to ramp, so some of the capital being deployed is defensive rather than accretive, and early utilization/yield friction could pressure gross margin before the strategic benefit is visible.

Second-order winners are the semiconductor equipment and process-control names that sit behind every incremental fab dollar: AMAT, LRCX, KLAC, and TER should see longer order visibility if U.S. localization continues. Relative losers are offshore foundry peers and any “single-country” supply-chain names that rely on concentration as a moat; the Arizona expansion chips away at that edge. The market should also think about substitution: if U.S. customers increasingly dual-source for security reasons, TSM’s share may be protected, but pricing power could be less elastic than in a pure scarcity cycle.

The key risk is that the AI capex narrative cools before the de-risking premium gets repriced. In the next 1-3 months, TSM will trade more on AI sentiment and Taiwan risk headlines than on Arizona milestones; over 6-12 months, the real test is whether advanced-node utilization stays tight enough to absorb higher U.S. depreciation. Contrarian view: consensus may be overestimating how much Arizona changes the risk profile; it lowers tail risk, but it does not eliminate concentration in a single strategic supply chain. If management’s next prints show any gross-margin degradation or a pause in leading-edge capacity commitments, the stock’s valuation support weakens quickly.

Key Decisions for Investors

• Long TSM on 5-8% pullbacks over the next 2-6 weeks; target 10-15% upside if AI utilization remains firm and geopolitical headlines stay contained. Falsify on a guide-down in advanced-node demand or gross margin compression of 150+ bps from U.S. ramp costs.
• Pair trade: long AMAT or LRCX vs short a basket of high-beta AI hardware names over 3-6 months. Thesis: the next leg of value accrues to the picks-and-shovels layer from fab localization, not just to end-demand beneficiaries that already discount perfect AI execution.
• Relative-value hedge: long TSM / short NVDA for 3-6 months if you want AI exposure with less valuation risk. TSM’s multiple is cheaper and more defensible if the market starts questioning how much AI capex is already priced into GPU names.
• Set a watch item on TSM gross margin and capex commentary into the next earnings cycle; if management signals U.S. fabs are dragging consolidated margins or delaying returns, trim longs and consider taking profit on the multiple expansion story.
• If geopolitical risk reaccelerates, use TSM as a hedge only selectively; a Taiwan-specific escalation would override the Arizona de-risking and likely widen the risk premium faster than fundamentals can offset it.